These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
635 related items for PubMed ID: 10365592
1. [Antiarrhythmic agents in the prevention of sudden cardiac death]. Halawa B. Pol Merkur Lekarski; 1999 Mar; 6(33):117-20. PubMed ID: 10365592 [Abstract] [Full Text] [Related]
2. [Can sudden cardiac death be prevented by treatment with anti-arrhythmia drugs?]. Zrenner B, Koller B, Rudolph W. Herz; 1990 Apr; 15(2):90-102. PubMed ID: 2188895 [Abstract] [Full Text] [Related]
3. [Sudden cardiac death--possibilities and limits of drug therapy]. Manz M, Lüderitz B. Z Kardiol; 1992 May; 81(5):237-45. PubMed ID: 1621403 [Abstract] [Full Text] [Related]
4. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment. Castelli G, Ciaccheri M, Cecchi F, Troiani V, Nannini M, Marconi P, Olivotto J, Montereggi A, Dolara A. G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218 [Abstract] [Full Text] [Related]
6. [Preventive antifibrillatory treatment of sudden cardiac death in acute myocardial infarct]. Thale J, Gülker H, Hindricks G, Haverkamp W, Pollock B, Buchwalsky R. Z Kardiol; 1988 May; 77 Suppl 4():11-22. PubMed ID: 3062962 [Abstract] [Full Text] [Related]
7. Antiarrhythmic and nonantiarrhythmic drugs for sudden cardiac death prevention. Das MK, Zipes DP. J Cardiovasc Pharmacol; 2010 May; 55(5):438-49. PubMed ID: 20509177 [Abstract] [Full Text] [Related]
8. Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD? Wichter T, Paul TM, Eckardt L, Gerdes P, Kirchhof P, Böcker D, Breithardt G. Herz; 2005 Mar; 30(2):91-101. PubMed ID: 15875097 [Abstract] [Full Text] [Related]
9. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects]. Gronda E, Mangiavacchi M, Andreuzzi B, Municinò A. Ital Heart J Suppl; 2001 Dec; 2(12):1278-83. PubMed ID: 11838348 [Abstract] [Full Text] [Related]
10. Sudden cardiac death--an approach to management of the patient at risk. Podrid PJ, Blatt CM. Herz; 1984 Apr; 9(2):65-76. PubMed ID: 6714916 [Abstract] [Full Text] [Related]
12. [The patient at risk of sudden death:value of drug therapy]. Bonhorst D. Rev Port Cardiol; 2000 Feb; 19(2):233-9. PubMed ID: 10763353 [Abstract] [Full Text] [Related]
13. [New aspects of the clinical use of anti-arrhythmia agents with special reference to acute therapy of ventricular tachycardia (lidocaine vs. ajmaline)]. Manz M, Mletzko R, Jung W, Lüderitz B. Herz; 1990 Apr; 15(2):79-89. PubMed ID: 2188894 [Abstract] [Full Text] [Related]
14. [Primary prevention of sudden cardiac death implanted cardioverter defibrillator (ICD) versus antiarrhythmic drugs]. Iturralde Torres P. Arch Cardiol Mex; 2007 Apr; 77 Suppl 4():S4-129-32. PubMed ID: 18938711 [Abstract] [Full Text] [Related]
15. [Arrhythmia and anti-arrhythmia therapy as prognostic risks]. Meinertz T, Zehender M, Hofmann T, Hohnloser S, Just H. Herz; 1991 Sep; 16 Spec No 1():314-7, 323. PubMed ID: 1820298 [Abstract] [Full Text] [Related]
16. Sudden death secondary to cardiac arrhythmias: mechanisms and treatment strategies. Siddiqui A, Kowey PR. Curr Opin Cardiol; 2006 Sep; 21(5):517-25. PubMed ID: 16900017 [Abstract] [Full Text] [Related]
17. [Current management of patients with ventricular tachycardia]. Puljević D, Buljević B, Milicić D. Lijec Vjesn; 2001 Sep; 123(7-8):191-200. PubMed ID: 11729615 [Abstract] [Full Text] [Related]